These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10134378)

  • 1. Let the buyer beware!: An open letter to Europe's health ministers, analysts and policy makers.
    Iliffe S
    Health Care Anal; 1994 Feb; 2(1):77-9. PubMed ID: 10134378
    [No Abstract]   [Full Text] [Related]  

  • 2. Pricing in the NHS internal market.
    Ferguson B; Posnett J
    Health Econ; 1994; 3(3):133-6. PubMed ID: 7921056
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction to economics in the new NHS.
    Cairns J; Donaldson C
    Health Policy; 1993 Sep; 25(1-2):1-7. PubMed ID: 10129151
    [No Abstract]   [Full Text] [Related]  

  • 4. From managed competition to managed cooperation: theory and lessons from the British experience.
    Light DW
    Milbank Q; 1997; 75(3):297-341. PubMed ID: 9290632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Government is to rewrite competition legislation.
    Iacobucci G
    BMJ; 2013 Mar; 346():f1516. PubMed ID: 23468304
    [No Abstract]   [Full Text] [Related]  

  • 6. Private finance initiatives (PFIs).
    Errington S
    Community Pract; 2007 Apr; 80(4):44, 46. PubMed ID: 17455577
    [No Abstract]   [Full Text] [Related]  

  • 7. Economics and NHS reform.
    Castledine SG
    Br J Nurs; 2011 Feb 10-23; 20(3):199. PubMed ID: 21378647
    [No Abstract]   [Full Text] [Related]  

  • 8. Decision making in quasi-markets: a pedagogic analysis.
    Jones PR; Cullis JG
    J Health Econ; 1996 Apr; 15(2):187-208. PubMed ID: 10159109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NHS internal market: economic aspects of its medium-term development.
    Whynes DK
    Int J Health Plann Manage; 1993; 8(2):107-22. PubMed ID: 10133763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observations on the NHS reforms: an American perspective.
    Light DW
    BMJ; 1991 Sep; 303(6802):568-70. PubMed ID: 1812855
    [No Abstract]   [Full Text] [Related]  

  • 11. Outsourcing favours private companies and is unsustainable, says report.
    Kmietowicz Z
    BMJ; 2012 Dec; 345():e8234. PubMed ID: 23207508
    [No Abstract]   [Full Text] [Related]  

  • 12. Reforming the British National Health Service: implementation problems in London.
    James JH
    J Health Polit Policy Law; 1995; 20(1):191-210. PubMed ID: 7738318
    [No Abstract]   [Full Text] [Related]  

  • 13. Public competition versus mixed markets: an analytic comparison.
    Saltman RB; von Otter C
    Health Policy; 1989; 11(1):43-55. PubMed ID: 10303303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jubilant?
    Miller S
    Br J Gen Pract; 2015 Mar; 65(632):148. PubMed ID: 25733430
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulatory reform of the NHS internal market.
    Propper C
    Health Econ; 1995; 4(2):77-83. PubMed ID: 7613599
    [No Abstract]   [Full Text] [Related]  

  • 16. What competition can do for community services.
    Worksett D
    Health Serv J; 2012 Oct; 122(6325):16. PubMed ID: 23323474
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of health care markets.
    Goddard M
    J Health Serv Res Policy; 2003 Oct; 8(4):193-5. PubMed ID: 14596751
    [No Abstract]   [Full Text] [Related]  

  • 18. Economics in the new NHS.
    Health Policy; 1993 Sep; 25(1-2):1-183. PubMed ID: 10129150
    [No Abstract]   [Full Text] [Related]  

  • 19. NHS conference is warned of dangers of Transatlantic Trade and Investment Partnership.
    Limb M
    BMJ; 2015 Apr; 350():h1977. PubMed ID: 25868463
    [No Abstract]   [Full Text] [Related]  

  • 20. Organizational reform and health-care goods: concerns about marketization in the UK NHS.
    Cribb A
    J Med Philos; 2008 Jun; 33(3):221-40. PubMed ID: 18567904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.